Skip to content

Welcome to Discover Pharma! Today is : November 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Discovery & Development

  • Biotech & Pharma Business,Drug Discovery & Development

    Carta Healthcare raises $18.25M to expand AI-driven clinical data abstraction platform

    Carta Healthcare has secured $18.25 million in Series B1 financing [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development

    Gifthealth’s CEO on reimagining pharmacy access: From prescription to patient in a frictionless future

    With nearly 30 years of experience across pharma, precision medicine, [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development

    Elsevier expands database with ClinicalTrials.gov to support drug and device development

    Elsevier has announced the addition of over 500,000 clinical trial [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development

    Title21 appoints expert committee to support cell and gene therapy platform development

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development

    Hovione and Firstgene partner to accelerate gene therapy innovation for liver cancer

    Strategic collaboration combines advanced AAV-like particle technology with targeted oncology [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development

    Molecular Devices unveils automated QPix FLEX system to transform microbial colony picking

    New benchtop platform boosts speed, sterility, and accuracy for microbiology [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development

    New study urges EU to overhaul regulatory landscape to remain competitive in pharma innovation

    Research from Bayes Business School and Merck KGaA identifies barriers [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development

    Ethris secures €10 million EU4Health grant for ETH47 antiviral development

    Ethris GmbH has been awarded a €10 million grant from [...]

    May 5, 2026
  • Drug Discovery & Development

    SOTIO’s SOT109 targets CDH17 in colorectal cancer: A new ADC contender emerges

    SOTIO’s lead candidate, SOT109, is generating buzz in the ADC [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development

    EXCLUSIVE interview: How foundation models are redefining small molecule drug discovery

    As generative AI rapidly evolves, one of its most promising [...]

    May 5, 2026
Previous777879Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • NEJM study provides first clinical evidence for NET-degrading therapy in lupus
    Categories: Clinical & Regulatory, Drug Discovery & Development, Research & Development, Therapeutic Areas
  • Kairos reports positive interim Phase 1 safety data for ENV-105 in EGFR-mutated lung cancer
    Categories: Clinical & Regulatory, Drug Discovery & Development, Research & Development, Therapeutic Areas
  • Rani reports positive Phase 1 data for oral obesity therapy RT-114
    Categories: Clinical & Regulatory, Drug Delivery & Formulation, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top